FIELD: chemistry.
SUBSTANCE: invention relates to a pharmaceutically acceptable N-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridine carboxamide salt, where the salt is a mesylate or hydrochloride. The invention also relates to a pharmaceutical composition, having anti-tumour activity, which contains said salt and use of said salt when producing an anti-tumour drug. Also disclosed is a method of producing a pharmaceutically acceptable N-[4-(1-cyanocyclopentyl)phenyl]-2-(4-pyridylmethyl)amino-3-pyridine carboxamide salt, particularly a mesylate or hydrochloride thereof.
EFFECT: novel N salts have better stability and bioavailability.
4 cl, 5 ex, 9 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL FORMS CONTAINING AG013736 | 2004 |
|
RU2341263C2 |
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2665138C2 |
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2659725C2 |
| DERIVATIVES OF 2-AMINONICOTINE AMIDE AND THEIR USING AS INHIBITORS OF TYROSINE KINASE VEGF RECEPTORS | 2001 |
|
RU2296124C2 |
| CANCER MEDICAL TREATMENT | 2005 |
|
RU2325906C2 |
| USE OF RAPAMYCIN DERIVATIVE | 2011 |
|
RU2483727C1 |
| NEW COMPOUNDS | 2016 |
|
RU2747645C2 |
| INHIBITION OR PREVENTION OF DISTURBED ANGIOGENIC REGULATION WITH USING RAPAMYCIN DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING RAPAMYCIN DERIVATIVE | 2006 |
|
RU2445093C2 |
| DERIVATIVES OF 6-AMINO QUINAZOLINE OR 3-CYANOQUINOLINE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS INHIBITORS OF RECEPTOR TYROZINE KINASES EGFR OR HER-2 | 2010 |
|
RU2536102C2 |
| BIGETEROARYL-SUBSTITUTED 1,4-BENZODIAZEPINES AND WAYS OF THEIR USE FOR CANCER TREATMENT | 2016 |
|
RU2747644C2 |
